Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers
Authors
Keywords
-
Journal
CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-11
DOI
10.1016/j.clon.2023.10.049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
- (2023) Stephanie G C Kroeze et al. LANCET ONCOLOGY
- Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
- (2022) Austin J. Bartl et al. Cancers
- Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation
- (2022) J. Gough et al. CLINICAL ONCOLOGY
- Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
- (2022) Alison C Tree et al. LANCET ONCOLOGY
- 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
- (2022) Shankar Siva et al. LANCET ONCOLOGY
- SABR for primary renal cell carcinoma: single-fraction or multiple-fraction?
- (2022) Takashi Mizowaki LANCET ONCOLOGY
- Phase III Multi-Center, Prospective, Randomized Trial Comparing Single Dose 24 Gy Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
- (2021) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
- (2021) Per Fransson et al. LANCET ONCOLOGY
- Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer
- (2021) Carlo Greco et al. JAMA Oncology
- Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
- (2021) Arjun Sahgal et al. LANCET ONCOLOGY
- Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)
- (2021) Shankar Siva et al. JAMA Oncology
- Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?
- (2021) P. Ostler et al. CLINICAL ONCOLOGY
- Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer
- (2021) Gregory M.M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients
- (2020) William C. Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database
- (2020) Michael Xiang et al. RADIOTHERAPY AND ONCOLOGY
- A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
- (2020) Hamza Hasan et al. BMC CANCER
- Toxicity in combination immune checkpoint inhibitor and radiation therapy: a systematic review and meta-analysis
- (2020) Congzhou M. Sha et al. RADIOTHERAPY AND ONCOLOGY
- Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study
- (2020) Anastasia Chalkidou et al. LANCET ONCOLOGY
- Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death
- (2019) Chang W. Song et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken
- (2019) M.-C. Vozenin et al. CLINICAL ONCOLOGY
- Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
- (2019) William C. Jackson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
- (2019) Andrea Bezjak et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
- (2019) David A Palma et al. LANCET
- FLASH Radiotherapy: The Next Technological Advance in Radiation Therapy?
- (2019) P. Symonds et al. CLINICAL ONCOLOGY
- Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
- (2019) Marsha Reyngold et al. Radiation Oncology
- One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial
- (2019) Anurag K. Singh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631
- (2019) S. Ryu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
- (2019) Douglas H Brand et al. LANCET ONCOLOGY
- TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
- (2019) Jarad Martin et al. BMJ Open
- Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
- (2019) Thomas Zilli et al. RADIOTHERAPY AND ONCOLOGY
- Single Fraction Stereotactic Ablative Body Radiotherapy for Oligometastasis: Outcomes from 132 Consecutive Patients
- (2018) S. Gandhidasan et al. CLINICAL ONCOLOGY
- Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy
- (2018) Tanja Sprave et al. RADIOTHERAPY AND ONCOLOGY
- Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
- (2018) John Conibear et al. BMJ Open
- Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature
- (2018) G. Francolini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
- (2018) Shankar Siva et al. BMC CANCER
- Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
- (2018) Christy Goldsmith et al. Radiation Oncology
- A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non–Small Cell Lung Cancer
- (2017) A.K. Singh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiotherapy for Liver Metastases
- (2017) Karyn A. Goodman et al. SEMINARS IN RADIATION ONCOLOGY
- A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
- (2015) Jeffrey J. Meyer et al. ANNALS OF SURGICAL ONCOLOGY
- The Radiobiology of Hypofractionation
- (2015) Alan E. Nahum CLINICAL ONCOLOGY
- Evaluating Competing and Emerging Technologies for Stereotactic Body Radiotherapy and Other Advanced Radiotherapy Techniques
- (2015) A.G.R. Martin et al. CLINICAL ONCOLOGY
- Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases
- (2015) S. Siva et al. CLINICAL ONCOLOGY
- A Hypothesis: Indirect Cell Death in the Radiosurgery Era
- (2015) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
- (2015) Gregory M.M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Single- versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
- (2014) Erqi L. Pollom et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
- (2014) J. Martin Brown et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Ablative Body Radiation Therapy for Primary Kidney Cancer: A 3-Dimensional Conformal Technique Associated With Low Rates of Early Toxicity
- (2014) Daniel Pham et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer
- (2014) Nicholas Trakul et al. SEMINARS IN RADIATION ONCOLOGY
- Percutaneous Ablation for Small Renal Masses—Complications
- (2014) A. Kurup SEMINARS IN INTERVENTIONAL RADIOLOGY
- Clinical Outcomes of Single Dose Stereotactic Radiotherapy for Lung Metastases
- (2013) Mattia F. Osti et al. Clinical Lung Cancer
- Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases
- (2013) Andrea R. Filippi et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
- (2012) Christy Goldsmith et al. CANCER IMAGING
- Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer
- (2011) Devin Schellenberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Radiotherapy for Adrenal Gland Metastases: University of Florence Experience
- (2011) Franco Casamassima et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiotherapy: A Review
- (2010) A. Martin et al. CLINICAL ONCOLOGY
- Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver Malignancies
- (2010) Karyn A. Goodman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
- (2009) Daniel T. Chang et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started